MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Braveheart Investment completes proof of concept study of Paraytec Covid-19 test

StockMarketWire.com

Investment company Braveheart Investment said it had completed the proof of concept for a COVID-19 test that Paraytec was conducting with the University of Sheffield, and would now move on to securing approvals to finetune the test kit.



'Work will now turn toward the acquisition of clinically relevant data, to facilitate optimisation of the functional capabilities of the test, together with a programme of product refinement and development,' the company said.

'Meanwhile, regulatory approval for live virus trials and the acquisition of clinical data is being sought,' it added. At 9:06am: (LON:BRH) Braveheart Investment Group PLC share price was +14.5p at 50.5p



Story provided by StockMarketWire.com